Yuyu Pharma, Inc. total revenue, net income and dynamics of changes in South Korean won today
Yuyu Pharma, Inc. current income and income for the latest reporting periods. Net revenue Yuyu Pharma, Inc. is now 26 495 227 970 ₩. Information about net revenue is taken from open sources. The dynamics of Yuyu Pharma, Inc. net revenue increased by 1 829 735 450 ₩ from the last reporting period. Graph of finance company Yuyu Pharma, Inc.. The financial graph of Yuyu Pharma, Inc. shows the values and changes of such indicators: total assets, net income, net revenue. Yuyu Pharma, Inc. total revenue on the graph is shown in yellow.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
35 928 721 412 578.65 ₩
+19.6 % ↑
376 038 099 406.35 ₩
-77.905 % ↓
31/12/2020
33 447 517 804 283.40 ₩
+11.75 % ↑
-673 654 692 615.45 ₩
-157.849 % ↓
30/09/2020
34 579 900 227 019.05 ₩
+18.38 % ↑
926 743 093 808.10 ₩
-32.394 % ↓
30/06/2020
33 520 894 782 399.30 ₩
+8.9 % ↑
-1 436 363 992 844.85 ₩
-196.365 % ↓
30/09/2019
29 209 911 392 298.75 ₩
-
1 370 795 786 301 ₩
-
30/06/2019
30 782 571 129 082.35 ₩
-
1 490 539 861 936.95 ₩
-
31/03/2019
30 041 904 014 877.15 ₩
-
1 701 903 843 315.60 ₩
-
31/12/2018
29 929 410 549 130.80 ₩
-
1 164 500 877 418.20 ₩
-
Show:
to
Yuyu Pharma, Inc. financial report charts
Dates of Yuyu Pharma, Inc. finance reports: 31/12/2018, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The latest date of the financial report of Yuyu Pharma, Inc. is 31/03/2021. Gross profit Yuyu Pharma, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Yuyu Pharma, Inc. is 11 065 047 040 ₩
Yuyu Pharma, Inc. quarterly report dates
Cost of revenue Yuyu Pharma, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Yuyu Pharma, Inc. is 15 430 180 930 ₩ Total revenue Yuyu Pharma, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Yuyu Pharma, Inc. is 26 495 227 970 ₩ Operating income Yuyu Pharma, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Yuyu Pharma, Inc. is 456 440 760 ₩
Net income Yuyu Pharma, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Yuyu Pharma, Inc. is 277 305 030 ₩ Current assets Yuyu Pharma, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Yuyu Pharma, Inc. is 70 008 522 190 ₩ Total assets Yuyu Pharma, Inc. refers to the total amount of assets owned by a person or entity. Total assets Yuyu Pharma, Inc. is 160 113 574 460 ₩
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
15 004 701 713 356.80 ₩
14 477 538 216 133.50 ₩
16 704 854 075 389.95 ₩
14 901 307 106 153.70 ₩
14 245 936 998 867.45 ₩
15 880 202 076 968.25 ₩
15 521 809 892 817 ₩
14 410 952 243 575.35 ₩
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
20 924 019 699 221.85 ₩
18 969 979 588 149.90 ₩
17 875 046 151 629.10 ₩
18 619 587 676 245.60 ₩
14 963 974 393 431.30 ₩
14 902 369 052 114.10 ₩
14 520 094 122 060.15 ₩
15 518 458 305 555.45 ₩
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
35 928 721 412 578.65 ₩
33 447 517 804 283.40 ₩
34 579 900 227 019.05 ₩
33 520 894 782 399.30 ₩
29 209 911 392 298.75 ₩
30 782 571 129 082.35 ₩
30 041 904 014 877.15 ₩
29 929 410 549 130.80 ₩
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
618 954 210 394.20 ₩
71 452 262 084.70 ₩
2 041 788 481 218.75 ₩
2 267 172 313 522.50 ₩
2 098 034 000 431.65 ₩
3 879 139 903 006.95 ₩
2 576 257 847 165.40 ₩
1 804 029 856 860.75 ₩
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
376 038 099 406.35 ₩
-673 654 692 615.45 ₩
926 743 093 808.10 ₩
-1 436 363 992 844.85 ₩
1 370 795 786 301 ₩
1 490 539 861 936.95 ₩
1 701 903 843 315.60 ₩
1 164 500 877 418.20 ₩
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
1 750 993 106 250 ₩
2 008 804 381 650 ₩
2 016 452 475 450 ₩
1 027 521 402 030 ₩
226 728 011 910 ₩
11 850 477 255 ₩
1 102 573 068 600 ₩
548 670 723 495 ₩
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
35 309 767 202 184.45 ₩
33 376 065 542 198.70 ₩
32 538 111 745 800.30 ₩
31 253 722 468 876.80 ₩
27 111 877 391 867.10 ₩
26 903 431 226 075.40 ₩
27 465 646 167 711.75 ₩
28 125 380 692 270.05 ₩
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
94 934 706 473 138.56 ₩
87 419 549 168 161.50 ₩
94 548 291 402 095.11 ₩
99 761 972 143 492.06 ₩
85 602 056 510 101.20 ₩
92 328 213 053 333.56 ₩
89 676 917 005 125 ₩
93 390 360 738 987.75 ₩
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
217 121 212 078 610.72 ₩
210 052 736 010 194.12 ₩
203 389 483 045 080.62 ₩
207 385 177 361 795.41 ₩
180 548 953 692 185.25 ₩
182 283 854 124 244.06 ₩
180 437 629 923 735 ₩
183 372 968 066 526.47 ₩
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
30 639 801 246 621 ₩
27 558 663 857 519.55 ₩
33 641 058 594 644.10 ₩
42 535 394 335 738.20 ₩
32 937 445 165 975.80 ₩
34 524 854 916 114.75 ₩
23 138 995 901 550 ₩
36 567 850 494 350.70 ₩
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
26 748 653 334 611.40 ₩
33 231 828 202 080.15 ₩
32 994 162 778 695 ₩
37 681 193 177 417.55 ₩
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
59 566 623 504 960.60 ₩
62 813 075 241 615.60 ₩
62 579 359 963 755 ₩
65 570 279 502 720.60 ₩
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
32.99 %
34.46 %
34.68 %
35.76 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
149 335 667 373 251.56 ₩
153 317 075 755 891.34 ₩
131 218 218 875 403.75 ₩
118 042 341 786 435.61 ₩
117 010 024 378 691.41 ₩
115 796 179 206 955.66 ₩
114 381 880 452 900 ₩
114 578 818 773 326.86 ₩
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
2 374 060 567 261.35 ₩
5 942 109 671 521.20 ₩
1 813 093 187 025 ₩
2 878 227 304 143.15 ₩
Last revenue report of Yuyu Pharma, Inc. was 31/03/2021. According to last financial report total revenue in Yuyu Pharma, Inc. was 35 928 721 412 578.65 South Korean won and changed by +19.6% since last year. Net income in Yuyu Pharma, Inc. was 376 038 099 406.35 ₩ in last quartal, net income changes to -77.905%.
Current cash Yuyu Pharma, Inc. - the sum of all of the cash a company has on the date of report. Current cash Yuyu Pharma, Inc. is 22 594 973 800 ₩
Yuyu Pharma, Inc. stocks data
000225.KS stock price
Yuyu Pharma, Inc. stock price today, 000225.KS stock quote.
